Home GPCR & G Protein PACAP Receptor

PACAP Receptor

Other GPCR & G Protein Related Inhibitors

Hedgehog/Smoothened PKA CGRP Receptor Endothelin Receptor S1P Receptor Cannabinoid Receptor SGLT Opioid Receptor GPR CCR
Cat.No. Product Name Information Product Use Citations Product Validations
S8415 PACAP 1-38 PACAP 1-38 (Pituitary Adenylate Cyclase Activating Polypeptide 38) is a highly potent PACAP receptor agonist (Kd = 100 pM). It stimulates adenylate cyclase and phagocytosis.
International Journal of Biological Sciences, 2025, 2824-2842
Int J Biol Sci, 2025, 21(6):2824-2842
Biomed Pharmacother, 2024, 179:117427
S8416 PACAP 6-38 acetate PACAP 6-38 acetate is a PACAP (pituitary adenylate cyclase-activating polypeptide) non-stimulating competitive antagonist with an IC50 value of 2 nM. It also acts as a functional CARTp antagonist in vivo.
University of Otago, 2022,
Frontiers in Immunology, 2021, 714244
Front Immunol, 2021, 12:714244
S8414 PACAP 1-27 Pituitary adenylate cyclase activating polypeptide (PACAP 1-27) is a potent PACAP receptor antagonist.
Materials Express, 2023, Not specified
E7942 Fipexide Fipexide, a parachloro-phenossiacetic acid derivative, is an orally active nootropic that improves cognitive performance through dopaminergic neurotransmission. It reduces striatal adenylate cyclase activity, enhancing memory and cognitive function. It also acts as a chemical inducer in callus formation, shoot regeneration, and Agrobacterium infection.